Detalles de la búsqueda
1.
Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments.
Ann Oncol
; 34(6): 543-552, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36921693
2.
Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody-drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors: first-in-human dose-escalation study.
Ann Oncol
; 33(4): 416-425, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35026412
3.
Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines.
Ann Oncol
; 32(8): 959-967, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33836264
4.
Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study.
Ann Oncol
; 32(5): 600-608, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33539945
5.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer.
Ann Oncol
; 32(12): 1496-1510, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34411693
6.
Clinical development of therapies targeting TGFß: current knowledge and future perspectives.
Ann Oncol
; 31(10): 1336-1349, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32710930
7.
Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer.
Ann Oncol
; 31(10): 1366-1375, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32569727
8.
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.
Ann Oncol
; 31(10): 1320-1335, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32745693
9.
Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors.
Ann Oncol
; 31(5): 626-633, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32205017
10.
JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions.
Ann Oncol
; 31(7): 861-872, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32272210
11.
Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group.
Ann Oncol
; 31(2): 246-256, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31959341
12.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO.
Ann Oncol
; 31(3): 334-351, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32067677
13.
Circulating tumor DNA, and clinical features to guide rechallenge with BRAF inhibitors in BRAF-V600E mutated metastatic colorectal cancer.
Ann Oncol
; 35(2): 240-241, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37866812
14.
Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study.
Ann Oncol
; 30(1): 124-131, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30339194
15.
Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy.
Ann Oncol
; 30(3): 439-446, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30689692
16.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.
Ann Oncol
; 30(1): 34-43, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30475943
17.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.
Ann Oncol
; 30(1): 19-33, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30475956
18.
Design and conduct of early clinical studies of immunotherapy agent combinations: recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies.
Ann Oncol
; 29(11): 2175-2182, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30202892
19.
Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer.
Ann Oncol
; 29(1): 119-126, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28945848
20.
Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study.
Ann Oncol
; 29(3): 602-609, 2018 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29228087